Literature DB >> 22492224

Unnecessary life threatening complications after IVF in mixed connective tissue disease.

Zeev Blumenfeld.   

Abstract

Entities:  

Mesh:

Year:  2012        PMID: 22492224      PMCID: PMC3370051          DOI: 10.1007/s10815-012-9763-5

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


× No keyword cloud information.
  5 in total

Review 1.  Ovarian stimulation and embryo banking for fertility preservation in a woman with severe mixed connective tissue disease: Is it safe?

Authors:  Vasileios D Sioulas; Clarisa R Gracia
Journal:  J Assist Reprod Genet       Date:  2011-12-29       Impact factor: 3.412

2.  Use of a gonadotropin-releasing hormone analog for protection against premature ovarian failure during cyclophosphamide therapy in women with severe lupus.

Authors:  Emily C Somers; Wendy Marder; Gregory M Christman; Vladimir Ognenovski; W Joseph McCune
Journal:  Arthritis Rheum       Date:  2005-09

3.  Gonadotropin releasing hormone agonists may minimize cyclophosphamide associated gonadotoxicity in SLE and autoimmune diseases.

Authors:  Zeev Blumenfeld; Or Mischari; Naomi Schultz; Nina Boulman; Alexandra Balbir-Gurman
Journal:  Semin Arthritis Rheum       Date:  2011-08-24       Impact factor: 5.532

4.  Preservation of fertility and ovarian function and minimizing gonadotoxicity in young women with systemic lupus erythematosus treated by chemotherapy.

Authors:  Z Blumenfeld; D Shapiro; M Shteinberg; I Avivi; M Nahir
Journal:  Lupus       Date:  2000       Impact factor: 2.911

5.  Prevention of gonadal toxicity and preservation of gonadal function and fertility in young women with systemic lupus erythematosus treated by cyclophosphamide: the PREGO-Study.

Authors:  Karin Manger; Ludwig Wildt; Joachim R Kalden; Bernhard Manger
Journal:  Autoimmun Rev       Date:  2005-10-27       Impact factor: 9.754

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.